pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
VMT-01
Metastatic Melanoma
$CATXPerspective Therapeutics, Inc.
0 catalysts
Phase 2
VMT-a-NET
Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET)
$CATXPerspective Therapeutics, Inc.
0 catalysts
Preclinical
VNLG-152
Triple-Negative Breast Cancer (TNBC)
Isoprene Pharmaceuticals Inc
0 catalysts
Phase 2
VNX-101
← prev
page 38 of 62
next →
131
Pain89
Neurology1
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
Vironexis Biotherapeutics Inc
0 catalysts
Phase 2
VNX-202
Gastric Cancer
Vironexis Biotherapeutics Inc
0 catalysts
Phase 2
VT-3989
Malignant Pleural Mesothelioma
Vivace Therapeutics Inc
0 catalysts
Preclinical
VTRU-200
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Vitruviae LLC
0 catalysts
Preclinical
VV-169
Refractory Multiple Myeloma
$NVSNOVARTIS AG
0 catalysts
Phase 1
VVD-037
Solid Tumor
Vividion Therapeutics Inc
0 catalysts
Phase 1
VVD-850
Non-Small Cell Lung Cancer
Vividion Therapeutics Inc
0 catalysts
Preclinical
VXAHPV-16.1
Human Papillomavirus (HPV) Associated Cancer
$VXRTVaxart, Inc.
0 catalysts
Phase 2
VXM-01
Recurrent Glioblastoma Multiforme (GBM)
Vaximm AG
0 catalysts
Preclinical
Vaccine for Triple-Negative Breast Cancer
Triple-Negative Breast Cancer (TNBC)
Flow Pharma Inc
0 catalysts
Preclinical
Vaccine to Target IL15, IL15RA and CD80 for Acute Myeloblastic Leukemia
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
University of California San Francisco
0 catalysts
Phase 2
WP-1066
Glioblastoma Multiforme (GBM)
$MBRXMoleculin Biotech, Inc.
0 catalysts
Preclinical
WSD-0329
Glioblastoma Multiforme (GBM)
Wayshine Biopharma Inc
0 catalysts
Phase 1
WSD-0628
Astrocytoma
Wayshine Biopharma Inc
0 catalysts
Phase 2
WSD-0922
Non-Small Cell Lung Cancer
Wayshine Biopharma Inc
0 catalysts
Preclinical
WSD-1227
Glioblastoma Multiforme (GBM)
Wayshine Biopharma Inc
0 catalysts
Phase 2
WTX-330
Colorectal Cancer
$HOWLWerewolf Therapeutics, Inc.
0 catalysts
Phase 1
XB-010
Endometrial Cancer
$EXELEXELIXIS, INC.
0 catalysts
Phase 1
XB-371
Solid Tumor
$EXELEXELIXIS, INC.
0 catalysts
Phase 1
XB-628
Solid Tumor
$EXELEXELIXIS, INC.
0 catalysts
Preclinical
XBIO-020
Hematological Tumor
$XBIOXenetic Biosciences, Inc.
0 catalysts
Phase 1
XKH-002
Solid Tumor
Zhejiang Xinkanghe Biomedical Technology Co Ltd
0 catalysts
Phase 1
XL-309
Fallopian Tube Cancer
$EXELEXELIXIS, INC.
0 catalysts
Preclinical
XLNT-1
Metastatic Ovarian Cancer
Nami Therapeutics Corp
0 catalysts
Preclinical
XM-14601
Pancreatic Ductal Adenocarcinoma
Excellamol Inc
0 catalysts
Preclinical
XM-161SN38
High-Grade Glioma
Excellamol Inc
0 catalysts
Preclinical
XTX-501
Non-Small Cell Lung Cancer
$XLOXilio Therapeutics, Inc.
0 catalysts